Tadalafil API Exporters From India: A Buyer’s Guide to Sourcing, Compliance and Safety Context
Finding reliable Tadalafil API exporters from India takes more than a quick search and a directory listing. Sourcing an Active Pharmaceutical Ingredient is not the same as sourcing a chemical commodity, and when the ingredient is Tadalafil, a PDE5 inhibitor with real contraindications and boxed-warning-adjacent risks, the stakes for procurement and regulatory teams go beyond price and lead time. “Top exporter” claims on a supplier’s homepage are not a substitute for a Certificate of Analysis, a valid DMF, or a documented manufacturing role. This guide walks through what Tadalafil API actually is, the safety context your formulation and regulatory teams need on record, and the specific documentation that separates a qualified exporter from a listing on a directory page.
What Tadalafil API Is, and Why India Dominates the Export Market
Tadalafil is a PDE5 (phosphodiesterase type 5) inhibitor. As an Active Pharmaceutical Ingredient, it is the raw material that formulation manufacturers use to produce the finished dosage forms marketed under brand names such as Cialis and Adcirca, and their generic equivalents. Industry reporting estimates India produces roughly 95 metric tons of Tadalafil API annually and is the top global exporter of Cialis/tadalafil-family shipments by volume, with the global API market valued at approximately $1.45 billion in 2025 and projected to approach $2.7 billion by 2032. [Source: Industry Research, Volza trade data, Future Market Report]
India has a well-established base of Tadalafil API manufacturers and exporters serving pharmaceutical companies and buyers across international markets. The following companies are among the suppliers identified for Tadalafil API.
|
4 Pharmacopoeial grades (IP / BP / EP / USP) |
90+ Countries reported by the widest-reach supplier listed |
9 Indian suppliers profiled in this listing |
Tadalafil API Exporters in India
Chemox Pharma Pvt. Ltd.
GUJARAT WHO-GMP IP / BP / EP / USP
A Gujarat-based pharmaceutical manufacturer operating a WHO-GMP-compliant facility and supplying Tadalafil API in IP, BP, EP and USP grades. The company reports exports to more than 90 countries across regions including Asia, Africa and the Middle East.
Swapnroop Drugs & Pharmaceuticals
MAHARASHTRA IP / BP / EP / USP
Based in Maharashtra, the company supplies Tadalafil API in IP, BP, EP and USP grades and provides documentation to support pharmaceutical buyers and regulatory requirements in multiple international markets.
Atom Pharma
HIGH-PURITY API EXPORT LOGISTICS
Manufactures and exports high-purity Tadalafil API for pharmaceutical applications, with product documentation and logistical support for international buyers.
Jatan Exports
EXPORTER COMMERCIAL VOLUMES
An Indian pharmaceutical exporter supplying Tadalafil API for commercial pharmaceutical requirements, with product offerings covering different manufacturing and formulation needs.
Gonane Pharma
GMP CERTIFIED QUALITY DOCUMENTATION
Supplies GMP-certified Tadalafil API along with regulatory and quality documentation required for pharmaceutical procurement and international sourcing.
Century Pharmaceuticals Ltd.
R&D CAPABILITY QUALITY SYSTEMS
Provides Tadalafil API supported by pharmaceutical R&D capabilities and quality systems designed for international markets.
Sun Pharmaceutical Industries Ltd. and Cipla Ltd.
MULTINATIONAL IN-HOUSE API PRODUCTION
Two of India’s major multinational pharmaceutical companies, with extensive manufacturing, API production and international distribution capabilities.
Samex Overseas
MANUFACTURER & EXPORTER FLEXIBLE PACKING
Operates as a manufacturer and exporter of Tadalafil API, serving pharmaceutical buyers with products packaged for different commercial sourcing requirements.
On-Label vs. Off-Label Context (For Regulatory Reference Only)
Formulation teams sourcing Tadalafil API should track which indication the finished product will be registered for, since dosing forms differ:
- Erectile dysfunction (ED): FDA-approved on-label use, available as an as-needed dose and a lower once-daily dose. [Source: FDA Cialis prescribing information]
- Benign prostatic hyperplasia (BPH): FDA-approved once-daily use. [Source: FDA Cialis prescribing information]
- Pulmonary arterial hypertension (PAH): FDA-approved under the Adcirca brand, dosed differently from Cialis. [Source: FDA Adcirca prescribing information]
Any other use is off-label and outside the scope of what a bulk API buyer should be marketing to end users. Buyers formulating for a specific market should confirm the target indication against that country’s approved labeling before finalizing specifications.
|
171596-29-5
CAS Number
|
C22H19N3O4
Molecular Formula
|
~95 MT/yr
India’s est. annual output
|
Safety Profile Every Formulation and Regulatory Team Should Reference
Who should not take finished tadalafil products (per FDA labeling):
- Anyone taking any form of organic nitrate: co-administration is contraindicated due to potentiated, dangerous drops in blood pressure. [Source: FDA Cialis label, DailyMed]
- Anyone taking guanylate cyclase (GC) stimulators such as riociguat. [Source: FDA Cialis label]
- Anyone with a history of serious hypersensitivity to tadalafil. [Source: FDA Cialis label]
- Patients for whom sexual activity is inadvisable due to cardiovascular status. [Source: FDA Cialis label]
Alpha-blockers were previously contraindicated alongside tadalafil; the FDA later replaced that contraindication with precautionary labeling, since combining two vasodilators can still lead to hypotension. [Source: FDA label change, Urology Times] Common adverse effects reported in clinical trials include headache, flushing, dyspepsia and back pain. Rare but serious risks include priapism (an erection lasting more than 4 hours) and sudden vision or hearing loss, both of which require immediate medical attention. [Source: FDA Cialis prescribing information]
Note for exporters and content teams: this safety information is provided so B2B buyers and their regulatory/medical affairs staff understand the product they are sourcing. It should never be repurposed as dosing or usage advice for individual consumers, and export marketing should never suggest tadalafil products, whether branded or generic, can be purchased without a valid prescription and appropriate import authorization. Counterfeit or unverified “tadalafil API” offered outside documented, GMP-audited supply chains carries serious quality and legal risk for buyers.
![Safety Profile Every Formulation and Regulatory Team Should Reference Who should not take finished tadalafil products (per FDA labeling): Anyone taking any form of organic nitrate: co-administration is contraindicated due to potentiated, dangerous drops in blood pressure. [Source: FDA Cialis label, DailyMed] Anyone taking guanylate cyclase (GC) stimulators such as riociguat. [Source: FDA Cialis label] Anyone with a history of serious hypersensitivity to tadalafil. [Source: FDA Cialis label] Patients for whom sexual activity is inadvisable due to cardiovascular status. [Source: FDA Cialis label] Alpha-blockers were previously contraindicated alongside tadalafil; the FDA later replaced that contraindication with precautionary labeling, since combining two vasodilators can still lead to hypotension. [Source: FDA label change, Urology Times] Common adverse effects reported in clinical trials include headache, flushing, dyspepsia and back pain. Rare but serious risks include priapism (an erection lasting more than 4 hours) and sudden vision or hearing loss, both of which require immediate medical attention. [Source: FDA Cialis prescribing information] Note for exporters and content teams: this safety information is provided so B2B buyers and their regulatory/medical affairs staff understand the product they are sourcing. It should never be repurposed as dosing or usage advice for individual consumers, and export marketing should never suggest tadalafil products, whether branded or generic, can be purchased without a valid prescription and appropriate import authorization. Counterfeit or unverified "tadalafil API" offered outside documented, GMP-audited supply chains carries serious quality and legal risk for buyers.](https://tadalafil-seller.com/blog/wp-content/uploads/2026/08/ChatGPT-Image-Aug-26-2026-01_08_36-PM-1024x614.png)
Evaluating a Tadalafil API Exporter: What to Check
| Criterion | Why it matters |
|---|---|
| GMP / WHO-GMP / ISO certification | Confirms the facility follows recognized quality management and manufacturing standards. |
| Manufacturer vs. exporter vs. trader role | The seller may not be the party that manufactures, releases or registers the product; this affects accountability and documentation access. |
| DMF / CEP availability | Required for regulatory filings in many markets, including US ANDA submissions. |
| Certificate of Analysis (CoA) and impurity profile | Impurity levels and particle size affect bioequivalence and finished-product stability. |
| Export documentation support | COA, MSDS, TDS and country-specific compliance paperwork prevent shipment delays. |
| Pharmexcil / regulatory body registration | Indicates the exporter operates within India’s formal pharmaceutical export framework. |
API vs. Finished Dose: Which Sourcing Route Fits Your Need
| Bulk API | Finished Formulation | |
|---|---|---|
| Typical buyer | Formulation manufacturers, CDMOs | Distributors, licensed pharmacies |
| Key documents needed | DMF/CEP, CoA, impurity data | Marketing authorization, batch release, labeling |
| Approved dosing forms referenced | N/A (raw material) | As-needed and once-daily strengths per approved label |
This table compares sourcing routes and documentation needs only. It is not a claim that any one product form is safer or more effective than another.
When to Involve a Physician, Pharmacist or Regulatory Consultant
Procurement and formulation staff are not a substitute for licensed medical or regulatory professionals. Involve a physician or pharmacist for any question about how a finished tadalafil product should be dosed or prescribed to a patient, and involve a qualified regulatory affairs consultant before submitting a DMF, ANDA, or equivalent filing in your target market.
Frequently Asked Questions
Is it legal to export Tadalafil API from India?
Yes, when handled by a properly licensed manufacturer or exporter registered with the relevant Indian pharmaceutical export authorities, with full documentation. Buyers are separately responsible for complying with their own country’s import and pharmaceutical regulations.
What documents should I request from a Tadalafil API supplier?
At minimum, a Certificate of Analysis, MSDS, and evidence of GMP or ISO certification. Depending on your target market, you may also need a DMF or CEP reference.
Can Tadalafil be taken with nitrate medications?
No. FDA labeling states that co-administration with any form of organic nitrate is contraindicated because tadalafil can dangerously potentiate the blood-pressure-lowering effect of nitrates. This is safety information for formulation and labeling reference, not dosing advice.
What is the difference between Tadalafil API and finished Tadalafil tablets?
API is the unformulated active ingredient used by manufacturers to produce finished dosage forms. Finished tablets are the marketed, labeled product ready for dispensing under a valid prescription.
Who are the leading Tadalafil API manufacturers in India?
Several GMP-certified manufacturers and merchant exporters operate in this space. Buyers should evaluate each on certification, documentation, and manufacturing role rather than by reputation alone.
Ready to evaluate suppliers? Request a technical dossier, CoA, and DMF/CEP status from any shortlisted exporter before requesting a quote, and confirm their manufacturing role in writing.
Sources: FDA prescribing information for Cialis and Adcirca (accessdata.fda.gov, DailyMed); Urology Times reporting on the 2018 alpha-blocker label change; industry trade and market-size reporting (Volza, Industry Research, Future Market Report). Medically reviewed by [placeholder: Name, MD / PharmD credentials] prior to publication. Flagged for MLR review before this piece goes live, given the YMYL/prescription-drug subject matter.